Friday, October 23, 2020

Bharat Biotech to submit revised Phase 3 clinical trial protocol to DCGI by next...

Covaxin is India’s first vaccine candidate against Covid-19

source https://www.hindustantimes.com/health/bharat-biotech-to-submit-revised-phase-3-clinical-trial-protocol-to-dcgi-by-next-week/story-rbUi7XHjRjdFMPxYKnforO.html

No comments:

Post a Comment